C WorldWide Group Holding A S boosted its stake in shares of NovoCure Limited (NASDAQ:NVCR – Free Report) by 135.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 521,784 shares of the medical equipment provider’s stock after acquiring an additional 300,000 shares during the period. C WorldWide […]
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year price target among analysts […]
NovoCure (NASDAQ: NVCR) has recently received a number of price target changes and ratings updates: 4/3/2024 – NovoCure had its price target lowered by analysts at Wells Fargo & Company from $49.00 to $42.00. They now have an “overweight” rating on the stock. 3/27/2024 – NovoCure had its “neutral” rating reaffirmed by analysts at Wedbush. […]
NovoCure (NASDAQ:NVCR – Get Free Report) had its target price lowered by investment analysts at Wells Fargo & Company from $49.00 to $42.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price objective indicates a potential upside […]
NovoCure (NASDAQ:NVCR – Get Free Report) and Minerva Surgical (NASDAQ:UTRS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 84.6% of NovoCure shares […]